ProNAi Therapeutics, Inc. is a privately held biopharmaceutical company. To date, the company has raised $15 million in equity and convertible notes.

ProNAi’s major investors include:

• Grand Angels, Grand Rapids, MI
• Biosciences Research Commercialization Center, Kalamazoo, MI
• Apjohn Ventures, Kalamazoo, MI
• Michigan Technology Tri-Corridor, Lansing, MI
• Sigvion Ventures, Chicago, IL
• 21st Century Jobs Fund, Lansing, MI
• Amherst Fund, Ann Arbor, MI